Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scoliosis Treatment: Evaluating Patient Suitability (STEPS)-A Multicenter Prospective Observational Cohort Study Comparing Short-Segment and Long-Segment Fusion in Degenerative Scoliosis

NCT07891676 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07891676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Scoliosis Treatment: Evaluating Patient Suitability (STEPS)-A Multicenter Prospective Observational Cohort Study Comparing Short-Segment and Long-Segment Fusion in Degenerative Scoliosis
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 31, 2029
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative scoliosis

Arms

As registered; 2 arms.

  • Short-Segment Fusion

    Participants undergoing instrumented spinal fusion involving fewer than four fused motion segments, selected through routine clinical decision-making.

  • Long-Segment Fusion

    Participants undergoing instrumented spinal fusion involving four or more fused motion segments, selected through routine clinical decision-making.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Achievement of the Minimum Clinically Important Difference in the Scoliosis Research Society-22r Subtotal Score Baseline and 24 months after surgery.

    Proportion of participants achieving an increase of more than 0.98 points from baseline in the Scoliosis Research Society-22r (SRS-22r) subtotal score. The subtotal score includes the function/activity, pain, self-image, and mental health domains and excludes the satisfaction domain. Scores range from 1 to 5, with higher scores indicating better health-related quality of life.

Lead sponsor's other trials

Xuanwu Hospital, Beijing, most recent start first.